Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
Condition: Opioid-use Disorder Interventions: Drug: Buprenorphine/naloxone; Drug: Placebo Sponsors: New York State Psychiatric Institute; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2021 Category: Research Source Type: clinical trials
OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
Condition: Opioid-use Disorder Interventions: Device: OXD01 digital therapy; Other: Standard of Care Sponsor: Orexo AB Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 1, 2021 Category: Research Source Type: clinical trials